Support WBURMedicare proposes covering expensive Alzheimer's drug for those in clinical trialsJonathan FranklinJanuary 11, 2022 ShareThe Biogen Inc., headquarters is shown in Cambridge, Mass. Medicare says it will limit coverage of a $28,200-per-year Alzheimer's drug whose benefits have been questioned. (AP)
